Berkeley, California
United States
48
2026-01-08
The entities that hold a legal rights for patent applications filed by inventor Brown Duncan:
Duncan Brown from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
INHIBITORS OF EXPRESSION AND/OR FUNCTION
#2 | 2025-12-25NUCLEIC ACID COMPOUNDS
#3 | 2025-10-09SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY
#4 | 2025-09-25COMPOSITIONS AND METHODS OF MODULATING XANTHINE DEHYDROGENASE
#5 | 2025-09-18TARGETED TREATMENT OF SPLICEOPATHY-INDUCED NEUROLOGICAL DISORDERS
#6 | 2025-08-14MUSK-TARGETING OLIGONUCLEOTIDES
#7 | 2025-03-27MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA
#8 | 2025-02-27RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#9 | 2025-02-13TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF UNC13A GENE TRANSCRIPTS
#10 | 2024-11-21MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH
#11 | 2024-10-10INHIBITORS OF EXPRESSION AND/OR FUNCTION
#12 | 2024-09-05MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING POMPE DISEASE
#13 | 2024-07-25RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#14 | 2024-07-04MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA
#15 | 2024-04-04MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#16 | 2024-03-28OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#17 | 2024-03-28OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#18 | 2024-01-18OLIGONUCLEOTIDES USEFUL FOR MODULATION OF SPLICING
#19 | 2023-06-29MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH
#20 | 2023-05-11SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY
#21 | 2023-04-13MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH
#22 | 2023-02-02RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#23 | 2022-12-01RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#24 | 2022-11-24PPM1A INHIBITORS AND METHODS OF USING SAME
#25 | 2022-10-20OLIGONUCLEOTIDES AND METHODS OF USE FOR TREATING NEUROLOGICAL DISEASES
#26 | 2021-03-25Modified Guide RNAs for Gene Editing
#27 | 2021-01-14Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#28 | 2020-10-22RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA)
#29 | 2020-06-25RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA)
#30 | 2019-10-31RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#31 | 2019-02-28Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#32 | 2018-07-12RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)
#33 | 2018-04-12RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#34 | 2018-02-01RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
#35 | 2017-02-02RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
#36 | 2016-12-22RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#37 | 2016-10-13RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#38 | 2016-09-08RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION
#39 | 2016-09-08Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#40 | 2016-03-17RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#41 | 2014-11-20RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)
#42 | 2014-04-03RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression
#43 | 2014-03-27Methods of Predicting The Probability of Modulation of Transcript Levels By RNAI Compounds
#44 | 2013-12-05RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
#45 | 2013-06-27RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#46 | 2013-06-13RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#47 | 2013-05-30RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
#48 | 2012-03-22Methods of Predicting The Probability of Modulation of Transcript Levels By RNAI Compounds
288021 ⎘